Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
10.18632/oncotarget.9579
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Impact Journals LLC
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/175457 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-175457 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1754572024-04-05T09:03:16Z Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads Kaminska, K.K Bertrand, H.C Tajima, H Stafford, W.C Cheng, Q Chen, W Wells, G Arner, E.S.J Chew, E.-H PHARMACY antineoplastic agent apoptosis signal regulating kinase 1 caspase 3 glutathione peroxidase glutathione reductase indolin 2 one derivative mitogen activated protein kinase p38 nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase oxidoreductase inhibitor selenocysteine stress activated protein kinase thioredoxin unclassified drug antineoplastic agent antioxidant glutathione peroxidase glutathione reductase indole derivative indolin-2-one juglone naphthoquinone reactive oxygen metabolite recombinant protein selenocysteine thioredoxin thioredoxin reductase TXN protein, human antineoplastic activity apoptosis Article breast carcinoma carboxy terminal sequence colorectal cancer drug selectivity drug structure drug targeting electrophilicity enzyme activation enzyme active site enzyme inhibition enzyme metabolism HCT116 cell line human human cell MCF 7 cell line oxidative stress protein cleavage signal transduction animal antagonists and inhibitors bovine chemistry drug design drug screening fibroblast HCT 116 cell line IC50 MCF-7 cell line metabolism mouse protein domain rat Animals Antineoplastic Agents Antioxidants Catalytic Domain Cattle Drug Design Drug Screening Assays, Antitumor Fibroblasts Glutathione Peroxidase Glutathione Reductase HCT116 Cells Humans Indoles Inhibitory Concentration 50 MCF-7 Cells Mice Naphthoquinones Oxidative Stress Protein Domains Rats Reactive Oxygen Species Recombinant Proteins Selenocysteine Thioredoxin-Disulfide Reductase Thioredoxins 10.18632/oncotarget.9579 Oncotarget 7 26 40233-40251 2020-09-10T01:45:29Z 2020-09-10T01:45:29Z 2016 Article Kaminska, K.K, Bertrand, H.C, Tajima, H, Stafford, W.C, Cheng, Q, Chen, W, Wells, G, Arner, E.S.J, Chew, E.-H (2016). Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads. Oncotarget 7 (26) : 40233-40251. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.9579 19492553 https://scholarbank.nus.edu.sg/handle/10635/175457 Impact Journals LLC Unpaywall 20200831 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
antineoplastic agent apoptosis signal regulating kinase 1 caspase 3 glutathione peroxidase glutathione reductase indolin 2 one derivative mitogen activated protein kinase p38 nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase oxidoreductase inhibitor selenocysteine stress activated protein kinase thioredoxin unclassified drug antineoplastic agent antioxidant glutathione peroxidase glutathione reductase indole derivative indolin-2-one juglone naphthoquinone reactive oxygen metabolite recombinant protein selenocysteine thioredoxin thioredoxin reductase TXN protein, human antineoplastic activity apoptosis Article breast carcinoma carboxy terminal sequence colorectal cancer drug selectivity drug structure drug targeting electrophilicity enzyme activation enzyme active site enzyme inhibition enzyme metabolism HCT116 cell line human human cell MCF 7 cell line oxidative stress protein cleavage signal transduction animal antagonists and inhibitors bovine chemistry drug design drug screening fibroblast HCT 116 cell line IC50 MCF-7 cell line metabolism mouse protein domain rat Animals Antineoplastic Agents Antioxidants Catalytic Domain Cattle Drug Design Drug Screening Assays, Antitumor Fibroblasts Glutathione Peroxidase Glutathione Reductase HCT116 Cells Humans Indoles Inhibitory Concentration 50 MCF-7 Cells Mice Naphthoquinones Oxidative Stress Protein Domains Rats Reactive Oxygen Species Recombinant Proteins Selenocysteine Thioredoxin-Disulfide Reductase Thioredoxins |
spellingShingle |
antineoplastic agent apoptosis signal regulating kinase 1 caspase 3 glutathione peroxidase glutathione reductase indolin 2 one derivative mitogen activated protein kinase p38 nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase oxidoreductase inhibitor selenocysteine stress activated protein kinase thioredoxin unclassified drug antineoplastic agent antioxidant glutathione peroxidase glutathione reductase indole derivative indolin-2-one juglone naphthoquinone reactive oxygen metabolite recombinant protein selenocysteine thioredoxin thioredoxin reductase TXN protein, human antineoplastic activity apoptosis Article breast carcinoma carboxy terminal sequence colorectal cancer drug selectivity drug structure drug targeting electrophilicity enzyme activation enzyme active site enzyme inhibition enzyme metabolism HCT116 cell line human human cell MCF 7 cell line oxidative stress protein cleavage signal transduction animal antagonists and inhibitors bovine chemistry drug design drug screening fibroblast HCT 116 cell line IC50 MCF-7 cell line metabolism mouse protein domain rat Animals Antineoplastic Agents Antioxidants Catalytic Domain Cattle Drug Design Drug Screening Assays, Antitumor Fibroblasts Glutathione Peroxidase Glutathione Reductase HCT116 Cells Humans Indoles Inhibitory Concentration 50 MCF-7 Cells Mice Naphthoquinones Oxidative Stress Protein Domains Rats Reactive Oxygen Species Recombinant Proteins Selenocysteine Thioredoxin-Disulfide Reductase Thioredoxins Kaminska, K.K Bertrand, H.C Tajima, H Stafford, W.C Cheng, Q Chen, W Wells, G Arner, E.S.J Chew, E.-H Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads |
description |
10.18632/oncotarget.9579 |
author2 |
PHARMACY |
author_facet |
PHARMACY Kaminska, K.K Bertrand, H.C Tajima, H Stafford, W.C Cheng, Q Chen, W Wells, G Arner, E.S.J Chew, E.-H |
format |
Article |
author |
Kaminska, K.K Bertrand, H.C Tajima, H Stafford, W.C Cheng, Q Chen, W Wells, G Arner, E.S.J Chew, E.-H |
author_sort |
Kaminska, K.K |
title |
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads |
title_short |
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads |
title_full |
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads |
title_fullStr |
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads |
title_full_unstemmed |
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads |
title_sort |
indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads |
publisher |
Impact Journals LLC |
publishDate |
2020 |
url |
https://scholarbank.nus.edu.sg/handle/10635/175457 |
_version_ |
1800914371324411904 |